Primary Vs. Postchemotherapy Retroperitoneal Lymph Node Dissection For Germ Cell And Testicular Cancer: Inter-and Postoperative Complications

Main Category: Urology / Nephrology
Also Included In: Cancer / Oncology
Article Date: 15 Jun 2008 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:not yet rated


ORLANDO, FL (UroToday.com) - The authors examined their series of 216 patients with testis cancer who underwent retroperitoneal lymph node dissection (RPLND). 117 patients had primary-RPLND (P-RPLND), while 99 patients were subjected to post-chemotherapy dissections (PC-RPLND). The authors compared clinical data from the P-RPLND group and the PC-RPLND patients. Blood loss was higher in the PC-RPLND group (1,500 cc vs 600 cc, p<0.0001). PC-RPLNDs was also a longer operation (353 minutes vs 279 minutes, p<0.0001). No statistical difference was seen in major vascular injuries (those requiring intraoperative consultation with a vascular surgeon) in the PC-RPLND group (n=11) when compared to the P-RPLND patients (n=6). The authors used a grading scale to classify complications that occurred intraoperatively or within 30 days of surgery:

Grade I - medical management
Grade III - procedure or re-operation needed
Grade IV - chronic disability
Grade V - death

37% of patients who underwent PC-RPLND and 27% of patients following P-RPLND experienced some type of complication. Unlike reports by other groups, this difference did not reach statistical significance. Patients in the PC-RPLND group were more likely to have a non-Grade I complication. Subdivision of complications by grade was as follows:

I Grade P-RPLND 25 (64%) - PC-RPLND 30 (57%)
II Grade P-RPLND 9 (23%) - PC-RPLND 16 (31%)
III Grade P-RPLND 5 (13%) - PC-RPLND 4 (8%)
IV Grade P-RPLND 0 (0%) - PC-RPLND 1 (2%)
V Grade P-RPLND 0 (0%) - PC-RPLND 1 (2%)

Reports such as this from centers that perform high volumes of these difficult and rare operations are very valuable to the urological community at large.

Presented by Vairavan S Subramanian, MD, Carvell T Nguyen, MD, Andrew J Stephenson, MD, and Eric A Klein, MD, at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.

Reported by UroToday.com Contributing Editor Alexander Kutikov, MD

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday

Article adapted by Medical News Today from original press release.
Visit our urology / nephrology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Urotoday. "Primary Vs. Postchemotherapy Retroperitoneal Lymph Node Dissection For Germ Cell And Testicular Cancer: Inter-and Postoperative Complications." Medical News Today. MediLexicon, Intl., 15 Jun. 2008. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/111252.php>

APA
Urotoday. (2008, June 15). "Primary Vs. Postchemotherapy Retroperitoneal Lymph Node Dissection For Germ Cell And Testicular Cancer: Inter-and Postoperative Complications." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/111252.php.

Please note: If no author information is provided, the source is cited instead.


Urology / Nephrology

Most Popular Articles



Follow Our Urology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Urology / Nephrology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »